Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Calcimedica Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CALC
Nasdaq
8731
https://calcimedica.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Calcimedica Inc
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis
- Apr 24th, 2024 12:00 pm
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
- Mar 28th, 2024 11:00 am
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
- Mar 13th, 2024 12:00 pm
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
- Feb 28th, 2024 11:57 pm
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury
- Feb 13th, 2024 1:00 pm
CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 9:05 pm
CalciMedica Announces Private Placement of up to Approximately $55 Million
- Jan 22nd, 2024 1:00 pm
CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition
- Dec 11th, 2023 12:30 pm
CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
- Nov 9th, 2023 12:00 pm
CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition
- Nov 2nd, 2023 1:15 pm
CalciMedica Announces Upcoming Presentations and Events in September
- Sep 6th, 2023 11:30 am
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023
- Aug 31st, 2023 11:30 am
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
- Aug 10th, 2023 8:05 pm
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
- Aug 9th, 2023 11:30 am
CalciMedica Announces Relisting on Nasdaq
- Jun 12th, 2023 11:30 am
CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
- Jun 6th, 2023 11:30 am
CalciMedica Expands Executive Team with New Appointments
- May 23rd, 2023 11:30 am
CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
- May 15th, 2023 12:55 pm
Scroll